Anixa Biosciences Inc (NASDAQ:ANIX) had an increase of 1.06% in short interest. ... The SI to Anixa Biosciences Inc's float is 6.86%. ... their article: “Anixa Bio teams up Urology San Antonio for Cchek prostate cancer study – Seeking ...
News
- Bank of NT Butterfield & Son Ltd (NTB) to pay $0.44 on Nov 15, 2019; Anixa Biosciences (ANIX ...
- Emerald Bioscience to Present Research Data Related to its Glaucoma Drug Candidate, NB1111 ...
Emerald Bioscience to Present Research Data Related to its Glaucoma ... 2019, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
- Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its ...
- Collaboration with Texas Biomed, SwRI and UT Health San Antonio targets bladder cancer
San Antonio, Texas (October 30, 2019) - The San Antonio Medical Foundation (SAMF) has awarded Texas Biomedical Research Institute Professor ...
- Seattle Genetics: 3Q Earnings Snapshot
The biotechnology company posted revenue of $213.3 million in the period, which beat Street forecasts. Eight analysts surveyed by Zacks expected ...